IIZUKA Kazuhide

School of Medicine Department of MedicineAssistant Professor

Research Keyword

  • SARS-Cov-2(COVID19)
  • cancer immunity of AML
  • Myeloproliferative neoplasms
  • hematopoietic stem cell

Field Of Study

  • Life sciences, Infectious disease, SARS-Cov-2(COVID19)
  • Life sciences, Hematology and oncology, acute myeloid leukemia
  • Life sciences, Hematology and oncology, Myeloproliferative neoplasm
  • Life sciences, Hematology and oncology, Hematology

Career

  • May 2024 - Present
    日本大学医学部 臨床検査医学科 助教
  • Mar. 2018 - Present
    nihon university, 助手

Educational Background

  • Apr. 2011 - Mar. 2015
    Juntendo University, Medical, Medical

Award

  • Dec. 2022
    日本内科学会関東地方会, 関東地方会奨励賞・指導医賞
    ★SARS-CoV-2患者で異型リンパ球数>100は細菌合併感染リスクが高く抗菌薬併用が考慮される, Japan society
  • 日本医療検査科学会, 日本医療検査科学会 優秀演題賞
  • Plos one, top 25% most cited PLOS ONE articles
  • 日本血液学会, 第3回関東甲信越地方会優秀演題賞
  • Jun. 2023
    日本内科学会関東地方会, 日本内科学会関東地方会指導医賞
    化学療法後のEBV再活性化経過中に橋本病が合併し、チラージンS投与でEBV PCRが陰性化した1例
  • 医療検査科学会, JACLaS Award 2022 優秀演題賞(学部生部門),(指導医として)
    Japan society

Paper

  • ★von Willebrand factor activity levels are influenced by driver mutation status in polycythemia vera and essential thrombocythemia patients with well-controlled platelet counts
    Kazuhide Iizuka; Soji Morishita; Yuji Nishizaki; Yoshikazu Iizuka; Noriyoshi Iriyama; Tomonori Ochiai; Naotake Yanagisawa; Hajime Yasuda; Jun Ando; Akihiko Gotoh; Masami Takei; Yoshihiro Hatta; Hideki Nakamura; Tomohiro Nakayama; Norio Komatsu
    European Journal of hematology, Sep. 2022, Refereed
    Lead
  • ★Von Willebrand Factor (vWF) Levels and Platelet Counts Showed Strong Inverse Correlation in Calreticulin (CALR) Mutated ET, but Weak in JAK2V617F Mutated PV and ET
    iizuka kazuhide
    Blood, Nov. 2018
    Lead
  • Space disinfection using TiO2 photocatalyst reduces the incidence of febrile neutropenia in cancer patients
    Kazuhide Iizuka; Heihachiro Ochiai; Yoshikazu Iizuka; Sachio Tsuchida; Hiroshi Umemura; Junichi Somei; Yumiko Tanimichi; Katsuhiro Miura; Hideki Nakamura; Tomohiro Nakayama; Yoko Aida; Yoshihiro Hatta; Masami Takei
    Scientific Reports, Mar. 2025
  • Topological importance of CD8+ T-cell enrichment in the tumor microenvironment of classic Hodgkin lymphoma.
    Hiromichi Takahashi; Shun Ito; Yoko Nakanishi; Katsuhiro Miura; Haruna Nishimaki; Masaru Nakagawa; Shimon Otake; Takashi Hamada; Takashi Koike; Kazuhide Iizuka; Shinobu Masuda; Tomohiro Nakayama; Tetsuo Shimizu; Naoya Ishibashi; Hirofumi Kogure; Hideki Nakamura
    Annals of hematology, Jan. 2025
  • TAFRO Syndrome: Guidance for Managing Patients Presenting Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, Renal Insufficiency, and Organomegaly.
    Katsuhiro Miura; Haruna Nishimaki-Watanabe; Hiromichi Takahashi; Masaru Nakagawa; Shimon Otake; Takashi Hamada; Takashi Koike; Kazuhide Iizuka; Yuuichi Takeuchi; Kazuya Kurihara; Toshihide Endo; Shun Ito; Hironao Nukariya; Takahiro Namiki; Yoshiyuki Hayashi; Hideki Nakamura
    Biomedicines, Jun. 2024
  • Clinical entity of cytomegalovirus disease in patients with malignant lymphoma on bendamustine therapy: a single-institution experience.
    Noriyoshi Iriyama; Katsuhiro Miura; Hiromichi Takahashi; Masaru Nakagawa; Kazuhide Iizuka; Takashi Hamada; Takashi Koike; Kazuya Kurihara; Toshihide Endo; Tomohiro Nakayama; Yoshihiro Hatta; Hideki Nakamura
    Leukemia & lymphoma, Jan. 2023
  • [Thrombotic microangiopathy with gastrointestinal hemorrhage during carfilzomib therapy for multiple myeloma].
    Shuhei Matsumoto; Hiromichi Takahashi; Takashi Hamada; Katsuhiro Miura; Masaru Nakagwa; Kazuya Kurihara; Toshihide Endo; Takashi Koike; Kazuhide Iizuka; Noriyoshi Iriyama; Tomohiro Nakayama; Yoshihiro Hatta; Hideki Nakamura
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2023
  • Pulmonary Veno-Occlusive Disease after Autologous Stem Cell Transplantation.
    Takashi Hamada; Hiromichi Takahashi; Masaru Nakagawa; Hironao Nukariya; Shun Ito; Toshihide Endo; Kazuya Kurihara; Takashi Koike; Kazuhide Iizuka; Shimon Ohtake; Takashi Ichinohe; Toshiya Maebayashi; Katsuhiro Miura; Yoshihiro Hatta; Hideki Nakamura
    Case reports in oncology, 2023
  • Pirarubicin-based intensive chemotherapy followed by consolidative high-dose chemotherapies for peripheral T-cell lymphomas: A noncomparative phase 2 study.
    Hiromichi Takahashi; Katsuhiro Miura; Masaru Nakagawa; Haruna Nishimaki; Shun Ito; Hironao Nukariya; Kazuya Kurihara; Toshihide Endo; Takashi Koike; Takashi Hamada; Kazuhide Iizuka; Shimon Ohatake; Noriyoshi Iriyama; Tomohiro Nakayama; Shinobu Masuda; Yoshihiro Hatta; Hideki Nakamura
    Hematological oncology, Dec. 2022
  • Ideal dose intensity of R-CHOP in diffuse large B-cell lymphoma.
    Katsuhiro Miura; Hiromichi Takahashi; Masaru Nakagawa; Takashi Hamada; Yoshihito Uchino; Kazuhide Iizuka; Shimon Ohtake; Noriyoshi Iriyama; Yoshihiro Hatta; Hideki Nakamura
    Expert review of anticancer therapy, Jun. 2022
  • Clinical impact of central nervous system-directed therapies on intravascular large B-cell lymphoma: A single institution's experience.
    Hiromichi Takahashi; Haruna Nishimaki; Yoko Nakanishi; Takashi Hamada; Masaru Nakagawa; Kazuhide Iizuka; Yoshihito Uchino; Noriyoshi Iriyama; Katsuhiro Miura; Tomohiro Nakayama; Shinobu Masuda; Yoshihiro Hatta; Hideki Nakamura
    EJHaem, May 2022
  • Relationship between Carnitine Deficiency and Tyrosine Kinase Inhibitor Use in Patients with Chronic Myeloid Leukemia.
    Noriyoshi Iriyama; Katsuhiro Miura; Yoshihito Uchino; Hiromichi Takahashi; Masaru Nakagawa; Kazuhide Iizuka; Takashi Hamada; Takashi Koike; Kazuya Kurihara; Tomohiro Nakayama; Masami Takei; Yoshihiro Hatta; Hideki Nakamura
    Chemotherapy, Nov. 2021
  • Efficacy of introducing electronic cigarettes in smoker's polycythemia(和訳中)
    飯塚 和秀; 伊藤 駿; 忽滑谷 寛直; 遠藤 聖英; 栗原 一也; 小池 隆; 濱田 高志; 中川 優; 内野 慶人; 高橋 宏通; 三浦 勝浩; 入山 規良; 八田 善弘; 中山 智祥; 武井 正美
    日本血液学会学術集会, Sep. 2021
  • 新規治療薬時代以降に診断された多発性骨髄腫患者における治療モダリティーと予後の変遷
    吉田 努; 入山 規良; 内野 慶人; 高橋 宏通; 中川 優; 濱田 高志; 飯塚 和秀; 小池 隆; 栗原 一也; 遠藤 聖英; 野口 夕利花; 三浦 勝浩; 八田 善弘; 中山 智祥; 武井 正美
    日大医学雑誌, Feb. 2021
  • Absolute Lymphocyte Counts After Lenalidomide Initiation may Predict the Prognosis of Patients With Relapsed or Refractory Multiple Myeloma.
    Masaru Nakagawa; Noriyoshi Iriyama; Takuto Ishikawa; Katsuhiro Miura; Yoshihito Uchino; Hiromichi Takahashi; Takashi Hamada; Kazuhide Iizuka; Takashi Koike; Kazuya Kurihara; Tomohiro Nakayama; Yoshihiro Hatta; Masami Takei
    Cancer diagnosis & prognosis, 2021
  • Maintenance Therapy With Bortezomib and Dexamethasone for Transplant-ineligible Patients With Multiple Myeloma.
    Yurika Noguchi; Noriyoshi Iriyama; Hiromichi Takahashi; Yoshihito Uchino; Masaru Nakagawa; Takashi Hamada; Kazuhide Iizuka; Takashi Koike; Kazuya Kurihara; Toshihide Endo; Tsutomu Yoshida; Katsuhiro Miura; Tomohiro Nakayama; Yoshihiro Hatta; Masami Takei
    Cancer diagnosis & prognosis, 2021
  • MPC-1 expression in myeloma cells is associated with the efficacy of bortezomib therapy.
    Kazuya Kurihara; Noriyoshi Iriyama; Katsuhiro Miura; Yoshihito Uchino; Hiromichi Takahashi; Masaru Nakagawa; Kazuhide Iizuka; Takashi Hamada; Takashi Koike; Yoshihiro Hatta; Tomohiro Nakayama; Masami Takei
    Medical oncology (Northwood, London, England), Jul. 2019, Refereed, Not invited
  • A novel fusion gene involving PDGFRB and GCC2 in a chronic eosinophilic leukemia patient harboring t(2;5)(q37;q31).
    Noriyoshi Iriyama; Hiromichi Takahashi; Hiromu Naruse; Katsuhiro Miura; Yoshihito Uchino; Masaru Nakagawa; Kazuhide Iizuka; Takashi Hamada; Yoshihiro Hatta; Tomohiro Nakayama; Masami Takei
    Molecular genetics & genomic medicine, Apr. 2019, Refereed, Not invited
  • 気質化肺炎の急性増悪を合併し突然死に至ったsarcoidosis-lymphoma syndrome
    臨床血液, Aug. 2017, Refereed, Not invited
    Lead
  • Factor XI deficiency as a result of a novel Tyr347Stop nonsense mutation in an elderly Japanese woman.
    Jun Ando; Azuchi Masuda; Kazuhide Iizuka; Tomonori Ochiai; Naoki Shingai; Hajime Yasuda; Yasuhiro Homma; Erina Kobayashi; Eriko Morishita; Norio Komatsu
    Geriatrics & gerontology international, Jun. 2017, Refereed, Not invited
  • Acute exacerbation of organizing pneumonia leading to sudden death in a patient with sarcoidosis-lymphoma syndrome.
    Kazuhide Iizuka; Jun Ando; Azuchi Masuda; Tomonori Ochiai; Ran Tomomasa; Hajime Yasuda; Tomoiku Takaku; Yasunori Ota; Takashi Yao; Akihiko Gotoh; Norio Komatsu
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2017, Refereed, Not invited
  • Co-occurrence of hyperleukocytosis and elevated fibrin-fibrinogen degradation product levels is a risk factor for early intracranial hemorrhage in patients with de novo acute leukemia.
    Kunimoto Ichikawa; Yoko Edahiro; Akihiko Gotoh; Kazuhide Iiduka; Norio Komatsu; Michiaki Koike
    International journal of hematology, Nov. 2016, Refereed, Not invited
  • Clinical and radiological CLIPPERS features after complete remission of peripheral T-cell lymphoma, not otherwise specified.
    Ryota Nakamura; Yuji Ueno; Jun Ando; Hironari Matsuda; Azuchi Masuda; Kazuhide Iiduka; Naoki Shingai; Masashi Takanashi; Kazumasa Yokoyama; Norio Komatsu; Nobutaka Hattori
    Journal of the neurological sciences, May 2016, Refereed, Not invited
  • Congenital haptoglobin deficiency discovered on the occasion of anaphylaxis induced by platelet concentrate transfusion.
    Jun Ando; Azuchi Masuda; Kazuhide Iizuka; Tomonori Ochiai; Tomoiku Takaku; Toshiya Osawa; Eiko Shimada; Yoshihisa Watanabe; Norio Komatsu; Akimichi Osaka
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2016, Refereed, Not invited
  • Lack of Phenotypical and Morphological Evidences of Endothelial to Hematopoietic Transition in the Murine Embryonic Head during Hematopoietic Stem Cell Emergence.
    Kazuhide Iizuka; Tomomasa Yokomizo; Naoki Watanabe; Yosuke Tanaka; Motomi Osato; Tomoiku Takaku; Norio Komatsu
    PloS one, 2016, Refereed, Not invited
    Lead

MISC

  • 難治性免疫・アレルギー疾患の病態の解明と新規治療法の開発
    岡山 吉道; 佐野 有隆; 豊島 翔太; 三木 寿美; 武富 芳隆; 坂本 朋美; 李 賢鎬; 齋藤 修; 村上 誠; 田杭 真帆; 伊東 真奈; 遠藤 嵩大; 丹羽 悠介; 葉山 惟大; 藤田 秀樹; 高橋 宏通; 三浦 勝浩; 濱田 岳志; 中川 優; 飯塚 和秀; 内野 慶人; 入山 規良; 小池 隆; 栗原 一也; 都築 広; 長澤 洋介; 長塚 靖子; 岩田 光浩; 北村 登; 丸岡 秀一郎; 福田 麻佐美; 山田 志保; 黒澤 雄介; 伊藤 亮治; 八田 善弘; 中山 智祥; 武井 正美; 徳橋 泰明; 權 寧博; 照井 正
    日本大学医学部総合医学研究所紀要, Dec. 2020
  • 中枢神経浸潤を合併した多発性骨髄腫に大量メルファラン療法とポマリドマイドが奏効した一例
    森洋輔; 白根脩一; 白根脩一; 枝廣陽子; 飯塚和秀; 飯塚和秀; 角南義孝; 小松則夫; 小池道明
    臨床血液, 30 Sep. 2016
  • JAK2V617F陽性ETから病型移行したと考えられたRUNX1‐RUNX1T1陽性AML‐M2
    落合友則; 飯塚和秀; 森下総司; 増田安土; 安藤純; 後藤明彦; 小松則夫
    臨床血液, 30 May 2015
  • 典型的症状出現前に早期診断ができた血管内大細胞型B細胞リンパ腫の1例
    落合友則; 飯塚和秀; 安藤純; 田中勝; 志賀教克; 小川尊資; 太田泰徳; 小松則夫
    日本内科学会関東支部関東地方会, 2014
  • マウス胎仔脳血管における造血幹細胞発生の可能性について
    飯塚 和秀; 横溝 智雅; 安田 肇; 小林 洋平; 高久 智生; 小松 則夫
    順天堂醫事雑誌, Dec. 2013

Books and other publications

  • ゴールドマン・セシル内科学 日本語対応電子書籍版 骨髄異形成症候群、骨髄増殖性腫瘍部分
    エルゼビア・ジャパン株式会社, Jul. 2021
  • 骨髄増殖性腫瘍におけるvWF活性高値は血栓症合併の可能性を示唆させる
    MTJ(ザ・メディカル&テストジャーナル)

Lectures, oral presentations, etc.

  • 院内感染症予防における光触媒搭載型空気清浄機の有効性についての検討
    飯塚 和秀
    Jun. 2022
  • Efficacy of introducing electronic cigarettes in smoker's polycythemia
    Oct. 2021
  • 骨髄増殖性腫瘍におけるvWF活性高値は血栓症合併の可能性を示唆させる
    Oct. 2021, 医療検査科学会
  • 二次性骨髄線維症を見逃さないために~移行しやすい症例と生検のタイミング~
    Iizuka Kazuhide
    Novartis Hematology Web Seminar, Feb. 2020, Novartis Pharma K.K.
  • High JAK2 allele burden are at risk of reduced vWF activity in PV & ET patients, even if platelets are well controlled.
    Oct. 2019
  • 骨髄増殖性腫瘍における生検の重要性と治療のポイント
    飯塚 和秀
    m3 web 講演会, Aug. 2019
  • Von Willebrand factor (vWF) levels and platelet counts showed strong inverse correlation in calreticulin (CALR) mutated ET, but weak in JAK2V617F mutated PV and ET
    American society of hematology, Dec. 2018
  • Efficacy of GDP for anti-L-asparaginase antibody positive and/or SMILE resistant NK/T lymphoma
    Japanese society of hematology, Oct. 2016

Courses

  • laboratory medicine
    Apr. 2019 - Present
  • hematology
    Apr. 2019 - Present
    Nihon university
  • 血液内科学
    順天堂大学医学部

Research Request Themes

  • myelo proliferative neoplasm

Research Themes

  • 光触媒を用いた感染予防・化学物質過敏症に対する効果について
    カルテック株式会社, 産学連携, Apr. 2022 - Mar. 2027
  • 急性骨触性白血病の緩解維持・再発に対するNK活性と白血病細胞表面抗原の重要性
    科学技術振興機構, 科研費
  • CD80/86陽性白血病細胞とNK活性の臨床的意義および3D画像解析を用いた白血病nicheの解明
  • Importance of NK activity and leukemia cell surface antigens in maintaining remission and predicting relapse of acute myeloid leukemia
    Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, 01 Apr. 2021 - 31 Mar. 2024
    飯塚 和秀